320 related articles for article (PubMed ID: 9193189)
1. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
Hsu CC; Herman JM; Corsini MM; Winter JM; Callister MD; Haddock MG; Cameron JL; Pawlik TM; Schulick RD; Wolfgang CL; Laheru DA; Farnell MB; Swartz MJ; Gunderson LL; Miller RC
Ann Surg Oncol; 2010 Apr; 17(4):981-90. PubMed ID: 20087786
[TBL] [Abstract][Full Text] [Related]
3. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
Neoptolemos JP; Stocken DD; Dunn JA; Almond J; Beger HG; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Lacaine F; Buckels J; Deakin M; Adab FA; Sutton R; Imrie C; Ihse I; Tihanyi T; Olah A; Pedrazzoli S; Spooner D; Kerr DJ; Friess H; Büchler MW;
Ann Surg; 2001 Dec; 234(6):758-68. PubMed ID: 11729382
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.
Lim JE; Chien MW; Earle CC
Ann Surg; 2003 Jan; 237(1):74-85. PubMed ID: 12496533
[TBL] [Abstract][Full Text] [Related]
5. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969
[TBL] [Abstract][Full Text] [Related]
6. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.
Chatterjee D; Katz MH; Rashid A; Varadhachary GR; Wolff RA; Wang H; Lee JE; Pisters PW; Vauthey JN; Crane C; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
Cancer; 2012 Jun; 118(12):3182-90. PubMed ID: 22028089
[TBL] [Abstract][Full Text] [Related]
7. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.
Katz MH; Merchant NB; Brower S; Branda M; Posner MC; William Traverso L; Abrams RA; Picozzi VJ; Pisters PW;
Ann Surg Oncol; 2011 Feb; 18(2):337-44. PubMed ID: 20811779
[TBL] [Abstract][Full Text] [Related]
8. On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer.
Garofalo MC; Regine WF; Tan MT
Ann Surg; 2006 Aug; 244(2):332-3; author reply 333. PubMed ID: 16858208
[No Abstract] [Full Text] [Related]
9. Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas.
Lominska CE; Unger K; Nasr NM; Haddad N; Gagnon G
Radiat Oncol; 2012 May; 7():74. PubMed ID: 22607687
[TBL] [Abstract][Full Text] [Related]
10. Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.
Aguilar LK; Shirley LA; Chung VM; Marsh CL; Walker J; Coyle W; Marx H; Bekaii-Saab T; Lesinski GB; Swanson B; Sanchez D; Manzanera AG; Aguilar-Cordova E; Bloomston M
Cancer Immunol Immunother; 2015 Jun; 64(6):727-36. PubMed ID: 25795132
[TBL] [Abstract][Full Text] [Related]
11. Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy.
McIntyre CA; Zambirinis CP; Pulvirenti A; Chou JF; Gonen M; Balachandran VP; Kingham TP; D'Angelica MI; Brennan MF; Drebin JA; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2021 Jan; 28(1):539-549. PubMed ID: 32451945
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of pancreatic cancer.
Collins A; Bloomston M
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):445-54. PubMed ID: 19942828
[TBL] [Abstract][Full Text] [Related]
13. Improved Overall Survival of Patients with Pancreatic Cancer through Multiagent Chemotherapy and Increased Rates of Surgical Resection.
Nicolais LM; Mohamed A; Macgillivray D; Verdini N; Inhorn R; Dugan M; Hayward CM; Fitzgerald TL
Am Surg; 2023 Dec; 89(12):5964-5971. PubMed ID: 37295019
[TBL] [Abstract][Full Text] [Related]
14. Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation.
Kirkegård J; Ladekarl M; Lund A; Mortensen F
Ann Surg Oncol; 2024 Feb; 31(2):1310-1318. PubMed ID: 37914923
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative electrochemotherapy of the posterior resection surface after pancreaticoduodenectomy: Preliminary results of a hybrid approach treatment of pancreatic cancer.
Čebron Ž; Djokić M; Petrič M; Čemažar M; Bošnjak M; Serša G; Trotovšek B
Bioelectrochemistry; 2024 Feb; 155():108576. PubMed ID: 37748261
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Cancer with Vascular Involvement: Adherence to Current Standard-of-Care Associated with Improved Survival.
Mohamed A; Nicolais L; Fitzgerald TL
Am Surg; 2023 Dec; 89(12):5535-5544. PubMed ID: 36854081
[TBL] [Abstract][Full Text] [Related]
17. Intensified Adjuvant Treatment for High-Risk Resected Cutaneous Angiosarcoma of the Head and Neck.
El Shatanofy M; Thakkar P; Patel V; Joshi A; Goodman J; Siegel R; Haroun F; Ojong-Ntui M; Goyal S; Bauman J; Rao YJ
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1225-1233. PubMed ID: 37464928
[TBL] [Abstract][Full Text] [Related]
18. The role of vascular resection and reconstruction in pancreaticoduodenectomy.
Li J; Liu Z; Xu X; Chen J
Asian J Surg; 2024 Jan; 47(1):63-71. PubMed ID: 37723030
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database.
Greco SH; August DA; Shah MM; Chen C; Moore DF; Masanam M; Turner AL; Jabbour SK; Javidian P; Grandhi MS; Kennedy TJ; Alexander HR; Carpizo DR; Langan RC
Surg Open Sci; 2021 Jan; 3():22-28. PubMed ID: 33490937
[TBL] [Abstract][Full Text] [Related]
20. Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma.
Clark E; Connor S; Taylor MA; Hendry CL; Madhavan KK; Garden OJ; Parks RW
HPB (Oxford); 2007; 9(6):472-7. PubMed ID: 18345298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
